logo

For the Inventor, By the Inventor

Boston, MA, United States of America

Aura Biosciences, Inc.

Calculating rank
USPTO Granted Patents = 12



Forward Citations = 89

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Elisabet De Los Pinos (12 out of 13 patents)

silverMedal Rhonda C Kines (9 out of 10 patents)

bronzeMedal John MacDougall (4 out of 5 patents)

4.  John T Schiller (4 out of 34 patents)

5.  Pierre L Coursaget (3 out of 3 patents)

6.  Maxime J J Fleury (3 out of 3 patents)

7.  Nicolas Combelas (3 out of 3 patents)

8.  Antoine A Touzé (2 out of 2 patents)

9.  Antoine A Touźe (1 out of 1 patent)

10.  John Todd Schiller (1 out of 1 patent)

11.  Stephen A Monks (0 patent)

12.  Antoine A Touze (0 patent)

13.  Maxime J Fleury (0 patent)

14.  Stephen A Monks (0 patent)


12 patents:

1. 12589165 - Methods for treating bladder tumors with viral nanoparticle conjugates and immune checkpoint inhibitors (2026-03-31),
2. 11806406 - Virus-like particle conjugates for diagnosis and treatment of tumors (2023-11-07),
3. 11110181 - Virus-like particle conjugates for diagnosis and treatment of tumors (2021-09-07),
4. 10688172 - HPV particles and uses thereof (2020-06-23),
5. 10596275 - Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells (2020-03-24),
6. 10588984 - Virus-like particle conjugates for diagnosis and treatment of tumors (2020-03-17),
7. 10300150 - Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells (2019-05-28),
8. 10179168 - HPV particles and uses thereof (2019-01-15),
9. 10117947 - Virus-like particle conjugates for diagnosis and treatment of tumors (2018-11-06),
10. 9855347 - Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells (2018-01-02),
11. 9724404 - HPV particles and uses thereof (2017-08-08),
12. 9700639 - Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells (2017-07-11),
Company Overview
Aura Biosciences, Inc. is a biotechnology company based in Boston, MA, specializing in the development of innovative therapies for cancer treatment. The company focuses on harnessing the power of viral-based technologies to create targeted therapies that aim to improve patient outcomes. With a commitment to advancing the field of oncology, Aura is dedicated to addressing unmet medical needs through its cutting-edge research and development efforts, positioning itself as a leader in the biopharmaceutical landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

12 Patents

#170 in Boston, MA

#1,549 in Massachusetts

#25,589 in US

#48,235 in the World

Boston, MA (US)
Boston, MA, United States of America

Aura Biosciences, Inc.

Forward Citations = 89

11 inventors:

goldMedal Elisabet De Los Pinos (12 out of 13 patents)

silverMedal Rhonda C Kines (9 out of 10 patents)

bronzeMedal John MacDougall (4 out of 5 patents)

4.  John T Schiller (4 out of 34 patents)

5.  Pierre L Coursaget (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Aura Biosciences, Inc.. Retrieved from https://idiyas.com/company/aura-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…